Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN101486687B details a low-toxicity synthesis of Setastine Hydrochloride using Xylene and PEG400, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN108047076B details a novel oseltamivir enantiomer route. Discover cost-effective manufacturing and high-purity supply chain solutions for antiviral intermediates.
Novel patent CN121494800A details green synthesis for cefixime intermediate offering high purity and supply chain reliability for pharmaceutical manufacturers.
Patent CN101161621A details a novel Heck reaction for trifluoromethyl acetophenone using solid base resin, offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel silylation method enhances yield and purity for pasireotide intermediate manufacturing, offering supply chain stability and cost efficiency.
Patent CN104666311A reveals a novel Cleistanone derivative synthesis offering high-purity pharmaceutical intermediates with significant supply chain and cost advantages for gout medication development.
Patent CN108033899B reveals a safe, ambient-temperature route for Atorvastatin intermediates. Discover cost reduction and supply chain advantages.
Patent CN103351325A details a selective borohydride reduction for Ropinirole intermediates, offering significant cost reduction in API manufacturing and enhanced supply reliability.
Novel isopropanol-based method eliminates toxic solvents ensuring high yield and supply chain stability for pharmaceutical manufacturing partners globally seeking reliable sources.
Patent CN107098855A reveals a mild DDQ-catalyzed dehydrogenation route for 7-hydroxy-2-quinolinone, offering high purity and reduced environmental impact for API manufacturing.
Patent CN103923022A details novel synthesis using alpha-pinene. Offers high purity pharmaceutical intermediates with significant supply chain and cost advantages for global buyers.
Patent CN117247928A details mutant acylase for 7-ACA. Offers greener, efficient production for reliable pharmaceutical intermediates supplier partners.
Patent CN103102254B details a high-yield Pterostilbene synthesis. Discover cost reduction in pharmaceutical intermediates manufacturing and supply chain advantages.
Patent CN1675167A reveals a high-yield route for 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol, offering superior stereoselectivity and scalable manufacturing for global API producers.
Patent CN111533694B reveals a novel one-step synthesis for 2-iminohydantoin compounds. Discover cost-effective manufacturing and high-yield supply chain solutions.
Patent CN110305122B reveals advanced C4-functionalized Pybox ligands offering superior enantioselectivity and streamlined synthesis for pharmaceutical intermediate manufacturing.
Patent CN103193843A reveals efficient acid-catalyzed synthesis for nucleoside triphosphates. Enhance supply chain reliability and reduce manufacturing costs for PCR reagents.
Novel manganese-catalyzed hydrogenation method for tetrahydropyridine derivatives offers high yield and supply chain stability for pharmaceutical intermediates manufacturing.
Patent CN102010323A details a green Pd-catalyzed synthesis for Ibuprofen. This route offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN114874118A reveals a one-pot synthesis route for N-methyl-D-prolinol, offering high purity and cost reduction for pharmaceutical intermediate manufacturing.